Part A: Technical Specifications: List of Products

Section VII – Technical Specifications 80
PART A: TECHNICAL SPECIFICATIONS

LIST OF PRODUCTS
Product Name Pharmacopoeia Dosage

No. Strength No. of Units Remarks
(Generic) Standards form
1. Rifampicin or I.P. or equivalent 75 mg Tablet All such tests necessary to
equivalent determine the conformity of
2. Rifampicin or I.P. or equivalent 150 mg Tablet the product with prescribed
equivalent standards / specifications
3. INH or I.P. or equivalent 75 mg Tablet will be conducted.
equivalent
4. INH or I.P. or equivalent 150 mg Tablet The drugs at Sl. No. 1, 2, 3,
equivalent As indicated in 4, 5, 6 , 7, 8 & 9 shall be in
5. Ethambutol or I.P. or equivalent 200 mg Tablet Schedule of Blister Combi Packs in
equivalent Requirements specified doses.
6. Ethambutol or I.P. or equivalent 400 mg Tablet
equivalent Specifications of packing
7. Pyrazinamide or I.P. or equivalent 250 mg Tablet materials are mentioned at
equivalent Clause 8.4 of part B,
8. Pyrazinamide or I.P. or equivalent 500 mg Tablet General Technical
equivalent Specifications.
9. Pyridoxine I.P. or equivalent 5 mg Tablet
* INH (Iso Nicotinic Acid Hydrazide)

PART B: GENERAL TECHNICAL SPECIFICATIONS
1 Product and package specifications
1.1 The pharmaceuticals and / or vaccines (including combipacks wherever necessary) to

be purchased by the Purchaser under this Invitation for Bids are included in the
Purchaser’s national essential drugs list or national formulary.
1.2 Product specifications indicate dosage form (e.g. tablet, liquid, injectable, emulsion,
suspension etc.) and the drug content (exact number of mg. or percentage v/v with
acceptable range). The products should conform to standards specified in one of the
following compendia: Indian Pharmacopoeia the British Pharmacopoeia, the United
States Pharmacopoeia, the French VIPAL Pharmacopoeia or the International
Pharmacopoeia. In case the pharmaceutical or vaccine is not included in the specified
compendium, the Supplier, upon award of the contract, must provide the reference
standards and testing protocols to allow for quality control testing.
1.3 Not only the pharmaceuticals or vaccine items, but also the packaging components
(e.g. bottles and closures) should also conform to specifications suitable for use in a
climate similar to that prevailing in the country of the Purchaser. All packaging must
be properly sealed and tamper-proof.
1.4 Pharmaceuticals and vaccines requiring refrigeration or freezing for stability must
specifically indicate storage requirements on labels and containers and be shipped in
the special containers to ensure stability in transit from point of shipment to the port
of entry.
2 Product information
2.1 The following information will be required for each pharmaceutical and vaccine
product offered by the Bidder:
i) International Non-proprietary Name (INN);

ii) Brand name (if it appears on label);
iii) Name and address of the manufacturer;
iv) Country of Origin; and
v) Compendia standards.
2.2 Upon award, the supplier shall on demand provide a translated version in the
language of the Bid of the prescriber’s information for any specific product the
Purchaser may request.
2.3 Failureto include any of this information, at the discretion of the Purchaser, render
the Bid non-responsive.
3 Expiration date
3.1 All products must indicate the dates of manufacture and expiry. In addition, unless
otherwise stated in Part A of these Specifications, all products must arrive at the port
of entry (for imported pharmaceuticals and vaccines) or consignees’ warehouse (for
local purchases) with a remaining shelf life of at least five-sixths (5/6ths) of the total
stipulated shelf life at the time of manufacture.
3.2 Shelf life of various Drugs would be as follows :
i) Rifampicin : shelf life should not be less than 32 months from the date of
manufacture.
ii) INH (Isoniazid) : shelf life should not be less than 56 months from the date of
manufacture.
iii) Ethambutol : shelf life should not be less than 56 months from the date of
manufacture.
iv) Pyrazinamide : shelf life should not be less than 56 months from the date of
manufacture.
v) Tab Pyridoxine (Vitamin B6) : shelf life should not be less than 32 months
from the date of manufacture.
For combipacks, the shelf life shall be the same as that of Rifampicin being the
constituent of combipack with the shortest shelf life.
4 Recalls
4.1 If products must be recalled because of problems with product quality or adverse
reactions to the pharmaceutical or vaccine, the Supplier will be obligated to notify the
purchaser providing full details about the reason leading to the recall and shall take
steps to replace the product in question at its own cost with a fresh batch of acceptable
pharmaceuticals or vaccines, or withdraw and give a full refund if the product has
been taken off the market due to safety problems.
5. Labeling instructions:
5.1 The label for each pharmaceutical and vaccine products shall meet the W210 GMP
standard and include:
i) the INN or generic name prominently displayed and above the brand name,
where a brand name has been given. Brand names should not be bolder or
larger than the generic name;
ii) the active ingredient “per unit dose, tablet or capsule, etc.;
iii) the applicable pharmacopoeia standard;
iv) content per pack;
v) special storage requirements;
vi) batch number; and
vii) date of manufacture and date of expiry.

5.1 The outer carton should also display the above information.
6.0 All cases should prominently indicate the following:
i) the generic name of the product;
ii) date of manufacture and expiry;
iii) batch number; and
iv) quantity per case.
No case should contain pharmaceutical or vaccine products from more than one
batch.
7. Unique identifiers
7.1 The Purchaser shall have the right to request the Supplier to imprint a logo on the
containers used for packaging and in certain dosage forms such as tablets and this will
be indicated in Part A of the Technical Specifications. The design of such logo shall
be provided to the Supplier at the time of Contract award.
8. Qualifications of manufacturer:
The Bidder shall furnish a certificate from the competent FDRA (Form 5) that the
manufacturer of the pharmaceutical or vaccine product covered by this Invitation for
Bid is licensed to manufacture these products.
9 Standards and quality assurance for supply
9.1 All products must:
a) meet the requirements of manufacturing legislation and regulation of

pharmaceuticals or vaccines in the country of origin;
b) conform to all the specifications contained herein; and
c) must undergo strict raw material inspection, in process checks, appropriate

material handling to eliminate cross contamination (of molecules) and final
product testing to ensure quality and consistency of the products.
9.2 The successful Bidder will be required to furnish to the purchaser :
a) with each consignment, a certificate of quality assurance test results

concerning quantitative assay, chemical analysis, sterility, pyrogen content
uniformity, microbial limit and other tests as applicable to the product being
supplied and Part A of these Specifications;
b) assay methodology of any or all tests if requested;

c) evidence of bio-availability and/or bio-equivalence for certain critical

pharmaceuticals or vaccines upon request;
d) evidence of basis for expiration dating and other stability data concerning the
commercial final package upon request.
9.3 The successful Bidder will also be required to provide the Purchaser with access to
its manufacturing facilities to inspect its facilities, quality control procedures for raw
materials, test methods, in-process tests, and finished dosage forms.
9.4 SPECIFICATION OF PACKAGING MATERIAL
9.4.1 General Specifications:
(i) The blister is TROPICIALIZED with moisture barrier properties for drug
stability under field condition.
(ii) Quality Assurance is according to Norm ISO 9001/EN 2901 of alu-foil.
(iii) Colour coded BCP’s.
(iv) Spacing between tablets allowing removal by patients with finger deformities.
(v) Complete with self-adhesive patient labels.
(vi) Outside box label with health worker instructions, if any, colour coded to
match contents.
(vii) Perforation and folding lines, to allow packet use.
(viii) The pharmaceuticals under Product Codes 13, 14, 15 & 16 will be supplied
duly packed in blister combi-packs which thereafter would be packed in
laminated pouches. These pouches would further be packed in millboard/
greyboard boxes and ultimately these would be put in 5-ply shippers for
dispatch.
9.4.2 Complex Constructions with PVC Films
Rigid PVC film thermoformable
XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX Polyethylene
XXXXXXXXXXXXXXXXX
Polyvinylidenechloride compound with
particularly high water vapour barrier
TECHNICAL DATA FOR THE STANDARD COMPLEXES
Complex:
Rigid PVC film gauge (microns) 200

PE coating (microns) 25
PVDC coating (gsm) 60
Total weight (gsm) 356
Complex gauge (mm) 0.280
Water Vapour Transmission Rate (W V T R):
Thermoformed:
20oC, 85% r.h., gsm/24 h 0.15

38oC, 90% r.h., gsm/24 h 0.7
Not thermoformed:
20oC, 85% r.h., gsm/24 h 0.06

38oC, 90% r.h., gsm/24 h 0.4
Shrinkage longitudinally
T = 140oC, t = 20 min. (%) 5–6

Application temperature (C) 68 – 74
r.h. = relative humidity

9.4.3 Packing Specifications
9.4.3.1 Anti-TB Pediatric Category (6-10 kg):
(a) Blister Combipack
PVC Film: Transparent, food grade, blister forming PVC film as

specified in 9.4.2
Aluminum Foil: 0.025 mm, VMCH coated Yellow coloured Aluminum

foil printed as per approved artwork.
Strip Size: Schedule – 5 : approximately 60 mm x 50 mm ± 10%

Schedule – 6 : approximately 135 mm x 50 mm ± 10%.
The configuration of the different drugs in the blister combi-pack will be as

indicated under para 9.4.4.1 and 9.4.4.2 – Configurations
(b) Laminated Pouch Two pouches will be required for each category of
treatment as specified in the schedule of requirement.
Each pouch will be labelled in Yellow colour as per
details given under para 9.4.5.1 – labels.
Laminated material Glassine paper (40 gm)/Aluminum (9um)/Poly (150

gauge)
Type of Pouch Gusseted
(a) Millboard/ Greyboard
Box: Each box will contain the combi-blister packs for one
patient and labelled in Yellow colour as given under para
9.4.5.1 – Labels.
Board: For patient-wise boxes, at least 3 mm corrugated card

board is to be used, surrounded on inside and outside by
tightly affix millboard of at least 400 gsm.
Style of box: Top and bottom tuck-in-flap type.
(b) 5-ply shipper Each shipper will contain 20-millboard/greyboard boxes

and labelled in Yellow Colour as per details given under
para 9.4.5.1 – Labels.
Description: RSC (Universal) type, 5-ply corrugated box made in narrow flute from
(150)5 gsm, virgin quality ‘A’ grade kraft paper.
9.4.3.2 Anti-TB Pediatric Category (11-17 Kg):

specified in 9.4.2
Aluminum Foil: 0.025 mm, VMCH coated Orange colour Aluminum foil
printed as per approved art
Strip Size: Schedule –7 : approximately 60 mm x 50 mm ± 10%
Schedule –8 : approximately 135 mm x 50 mm ± 10%.
The configuration of the different drugs in the blister strips will be as indicated
under para 9.4.4.3 and 9.4.4.4 – Configurations.
(b) Laminated Pouch Two pouches will be required for each category of
treatment as specified in the schedule of requirements.
Each pouch will contain the blister combi-packs strips
and labelled in Orange colour as per details given under
para 9.4.5.2 – Labels.

gauge)
(c) Millboard/Greyboard
Box: Each box will contain the combi-blister packs for one
patient and labelled in Orange colour as per details given
under para 9.4.5.2– Labels.

tightly affixed millboard of at least 400 gsm.
(d) 5-ply shipper Each shipper will contain 20-millboard/greyboard boxes

for 20 patients and labelled in Orange Colour as per
details given under para 9.4.5.2– Labels.
Description RSC (Universal) type, 5-ply corrugated box made in narrow

flute from (150)5 gsm, virgin quality ‘A’ grade kraft paper.
9.4.3.3 Product Code-15 Treatment box for prolongation of intensive phase of

Pediatric cases (18-25 kg)

specified in 9.4.2
Aluminum Foil: 0.025 mm, VMCH coated Yellow coloured Aluminum

foil printed as per approved artwork.
Strip Size: Schedule – 5 : approximately 60 mm x 50 mm ± 10%
The configuration of the drugs in the blister combi-pack will be as indicated under
para 9.4.4.1 – Configurations
(b) Laminated Pouch One extra month supply of schedule 5 drug in pouches,
each pouch containing 12 blister combi-packs. Each
pouch will be labelled in Pink colour as per details
given under para 9.4.5.3– labels.

gauge)
(c) Millboard/ Greyboard
Box: 5 pouches will be packed in a Millboard/Greyboard box

Each box will contain the combi-blister packs labelled
in Pink colour as given under para 9.4.5.3– Labels.

tightly affix millboard of at least 400 gsm.

and labelled in Pink Colour as per details given under
para 9.4.5.3– Labels.
Description: RSC (Universal) type, 5-ply corrugated box made in narrow flute from
(150)5 gsm, virgin quality ‘A’ grade kraft paper.
9.4.3.4 Product Code-16 Treatment box for prolongation of intensive phase of pediatric
cases (18-25 kg and 26-30kg)

specified in 9.4.2
Aluminum Foil: 0.025 mm, VMCH coated Orange colour Aluminum foil
printed as per approved art
Strip Size: Schedule –7 : approximately 60 mm x 50 mm ± 10%
The configuration of the drugs in the blister strips will be as indicated under para
9.4.4.3 – Configurations.
(c) Laminated Pouch One extra month supply of schedule 7 drug in pouches,
each pouch containing 12 blister combi-packs. Each
pouch will contain the blister combi-packs strips and
labelled in Grey colour as per details given under para
9.4.5.4– Labels.

gauge)
(c) Millboard/Greyboard
Box: 5 pouches will be packed in a Millboard/Greyboard box.

Each box will contain the combi-blister packs labelled in
Grey colour as per details given under para 9.4.5.4–
Labels.

tightly affixed millboard of at least 400 gsm.

labelled in Grey Colour as per details given under para
9.4.5.4 – Labels.
Description RSC (Universal) type, 5-ply corrugated box made in narrow

flute from (150)5 gsm, virgin quality ‘A’ grade kraft paper.
9.4.4 CONFIGURATIONS
9.4.4.1 Anti-TB Schedule 5
Z = Pyrazinamide Tablet 250 mg 1 Tablet

E = Ethambutol Tablet 200 mg 1 Tablet
H = Isoniazid Tablet 75 mg 1 Tablet
R = Rifampicin Tablet 75 mg 1 Tablet
“RNTCP SUPPLY
CGS – NOT FOR SALE”
R H
Z E
Mfg. Lic. No.

Z E H R
Batch No.
Mfg Date
Exp.Date
H = Isoniazid Tablet 75 mg 3 Tablets

R = Rifampicin Tablet 75 mg 3 Tablets
X = Pyridoxine Tablet 5 mg 4 Tablets
“RNTCP SUPPLY
Day 1
R H
Day 2
X
Day 3
R H
Day 4
X Mfg. Lic. No.

H R X
Day 5 Batch No.

Mfg Date
R H Exp.Date
Day 6
Day 7
X
Z = Pyrazinamide Tablet 500 mg 1 Tablet

E = Ethambutol Tablet 400 mg 1 Tablet
H = Isoniazid Tablet 150 mg 1 Tablet
R = Rifampicin Tablet 150 mg 1 Tablet
“RNTCP SUPPLY
R H
Z E
Mfg. Lic. No.

Z E H R
Batch No.
Mfg Date
Exp.Date
9.4.4.4 - Anti-TB Schedule 8
H = Isoniazid Tablet 150 mg 3 Tablets

R = Rifampicin Tablet 150 mg 3 Capsules
X = Pyridoxine Tablet 5 mg 4 Tablets
“RNTCP SUPPLY
Day 1
R H
Day 2
X
Day 3
R H
Day 4
X Mfg. Lic. No.

H R X
Day 5 Batch No.

Mfg Date
R H Exp.Date
Day 6
Day 7
X
9.4.5 Label Text for Laminated Pouch, Millboard Boxes and 5-Ply Shippers
9.4.5.1 Anti-TB Pediatric Category Product Code 13 (6-10 Kg):
LAMINATED POUCH
ANTI-TB PEDIATRIC CATEGORY (6-10Kg) ANTI-TB PEDIATRIC CATEGORY (6-10Kg)
24 Blister Combi-packs of one 18 Weekly Blister calendar Combi-packs

dose each (Schedule 5) (Schedule 6) for Continuation Phase
Z E H R H R X
Batch Nos:
Batch Nos:
Mfg Date:
Mfg Date:
Expiry Date:
Expiry Date:
“RNTCP - Central Government Supply

“RNTCP - Central Government Supply Not for Sale”
Not for Sale”
Manufacturer’s Name Manufacturer’s Name

Manufacturing Lic. No. Manufacturing Lic. No.
MILLBOARD/GREYBOARD BOX (Product Code 13)
ANTI-TB DRUG REGIMEN POUCH CATEGORY PEDIATRIC TREATMENT

(6-10Kg) CONTAINS DRUGS FOR THE FULL COURSE OF
TREATMENT FOR A PATIENT
24 Blister one dose Combi-packs 18 Weekly Blister Calendar

of Rifampicin (R), INH (H), Combi-packs of R, H, and Pyridoxine
Ethambutol (E) & Pyrazinamide (Z) (X)
Z E H R H R X
Batch Nos: Batch Nos:

Mfg. Date: Mfg. Date:
Exp. Date: Exp. Date:
“RNTCP – Central Government Supply

Not for Sale”
Manufacturer’s Name
Manufacturing Lic. No.
5 – PLY SHIPPER (Product Code 13)
ANTI-TB PEDIATRIC CATEGORY (6-10 Kg)

20 Millboard/Greyboard Boxes for 20 patients
Z E H R X
Batch Nos:
Mfg. Date:
Exp. Date:
“RNTCP– Central Government Supply
Not for Sale”
9.4.5.2 Anti-TB Category – Product Code 14 (11-17 Kg)
LAMINATED POUCH
ANTI-TB CATEGORY (11-17Kg) ANTI-TB CATEGORY (11-17 Kg)

24 Blister Combi-packs of one dose each 18 Weekly Blister calendar Combi-packs
(Schedule 7) for Intensive Phase (Schedule 8) for Continuation Phase
Z E H R H R X
Batch Nos:
Batch Nos:
Mfg Date:
Mfg Date:
Expiry Date:
Expiry Date:
“RNTCP - Central Government Supply – “RNTCP– Central Government Supply -

Not for Sale” Not for Sale”
Manufacturer’s Name Manufacturer’s Name

Manufacturing Lic. No. Manufacturing Lic. No.
MILLBOARD/GREYBOARD BOX (Product code 14)
ANTI-TB DRUG REGIMEN POUCH CATEGORY TREATMENT (11-

17Kg) CONTAINS DRUGS FOR THE FULL COURSE OF
TREATMENT FOR A PATIENT
24 Blister one dose Combi-packs of 18 Weekly Blister Calendar

Rifampicin (R), INH (H), Combi-packs of R, H, and
Ethambutol (E) & Pyrazinamide (Z) Pyridoxine (X)
Z E H R
H R X
Batch Nos: Batch No.:
Mfg. Date: Mfg. Date:
Exp. Date: Exp. Date:
“RNTCP– Central Government Supply

- Not for Sale”
ANTI-TB CATEGORY (11-17 Kg)

20 Millboard/Greyboard Boxes for 20 patients
Z E H R X
Batch No. :
Mfg. Date:
Exp. Date:
– Not for Sale”
9.4.5.3 Anti-TB Pediatric Category (Product code 15) (Prolongation of Intensive

Phase):
LAMINATED POUCH
ANTI-TB PEDIATRIC CATEGORY (6-10 Kg & 18-25 Kg)

PROLONGATION OF INTENSIVE PHASE
12 Blister Combi-packs of one dose each
(Schedule 5)
Z E H R
Batch No:
Mfg Date :
Expiry Date:

Not for Sale”
ANTI-TB DRUG REGIMEN POUCH CONTAINS DRUGS FOR

THE PROLONGATION OF INTENSIVE PHASE OF
PEDIATRIC CATEGORY – 6-10 Kg& 18- 25Kg (5 PATIENTS)
5 Pouches each contains 12 Blister of one dose Combi-packs of

Rifampicin (R), INH (H), Ethambutol (E) & Pyrazinamide (Z)
Z E H R
Batch Nos:
Mfg. Date:
Exp. Date:
Not for Sale”
ANTI-TB DRUG REGIMEN POUCH FOR THE PROLONGATION OF INTENSIVE

PHASE OF PEDIATRIC CATEGORY – 6-10 Kg& 18- 25Kg
20 Millboard/Greyboard Boxes
Z E H R X
Batch No. :
Mfg. Date:
Exp. Date:
– Not for Sale”
9.4.5.4 Anti-TB Pediatric Category (Product Code 16) (Prolongation of Intensive

Phase):
LAMINATED POUCH
ANTI-TB PEDIATRIC CATEGORY (11-17Kg, 18-25 Kg &26-30 Kg)

PROLONGATION OF INTENSIVE PHASE
12 Blister Combi-packs of one dose each
(Schedule 7)
Z E H R
Batch Nos:
Mfg Date :
Expiry Date:
“RNTCP Central Government Supply

- Not for Sale”
ANTI-TB DRUG REGIMEN POUCH CONTAINS DRUGS FOR

THE PROLONGATION OF INTENSIVE PHASE OF PEDIATRIC
CATEGORY -(11-17Kg, 18-25 Kg &26-30 Kg) (5 PATIENTS)
5 Pouches each contains 12 Blister of one dose Combi-packs of

Rifampicin (R), INH (H), Ethambutol (E) & Pyrazinamide (Z)
Z E H R
Batch Nos:
Mfg. Date:
Exp. Date:
– Not for Sale”
ANTI-TB DRUG REGIMEN POUCH FOR THE PROLONGATION OF INTENSIVE

PHASE OF PEDIATRIC CATEGORY -(11-17Kg, 18-25 Kg &26-30 Kg)
20 Millboard/Greyboard Boxes
Z E H R X
Batch No. :
Mfg. Date:
Exp. Date:
– Not for Sale”
9.4.6 Dimensions of Logo
Laminated Pouch
Mill / Grey Board

5 – Ply Shipper

Part A: Technical Specifications: List of Products

Hochgeladen von

Dokumentinformationen

Originalbeschreibung:

Originaltitel

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Part A: Technical Specifications: List of Products

Hochgeladen von

Copyright:

Verfügbare Formate

Section VII – Technical Specifications 80

PART A: TECHNICAL SPECIFICATIONS

Product Name Pharmacopoeia Dosage

* INH (Iso Nicotinic Acid Hydrazide)

PART B: GENERAL TECHNICAL SPECIFICATIONS

1 Product and package specifications

1.1 The pharmaceuticals and / or vaccines (including combipacks wherever necessary) to

i) International Non-proprietary Name (INN);

3.2 Shelf life of various Drugs would be as follows :

iii) the applicable pharmacopoeia standard;

iv) content per pack;

v) special storage requirements;

vi) batch number; and

vii) date of manufacture and date of expiry.

6.0 All cases should prominently indicate the following:

i) the generic name of the product;

ii) date of manufacture and expiry;

iii) batch number; and

iv) quantity per case.

9 Standards and quality assurance for supply

9.1 All products must:

a) meet the requirements of manufacturing legislation and regulation of

b) conform to all the specifications contained herein; and

c) must undergo strict raw material inspection, in process checks, appropriate

9.2 The successful Bidder will be required to furnish to the purchaser :

a) with each consignment, a certificate of quality assurance test results

b) assay methodology of any or all tests if requested;

c) evidence of bio-availability and/or bio-equivalence for certain critical

9.4 SPECIFICATION OF PACKAGING MATERIAL

9.4.1 General Specifications:

(ii) Quality Assurance is according to Norm ISO 9001/EN 2901 of alu-foil.

(iii) Colour coded BCP’s.

(v) Complete with self-adhesive patient labels.

(vii) Perforation and folding lines, to allow packet use.

9.4.2 Complex Constructions with PVC Films

Rigid PVC film thermoformable

TECHNICAL DATA FOR THE STANDARD COMPLEXES

Rigid PVC film gauge (microns) 200

Water Vapour Transmission Rate (W V T R):

20oC, 85% r.h., gsm/24 h 0.15

20oC, 85% r.h., gsm/24 h 0.06

T = 140oC, t = 20 min. (%) 5–6

r.h. = relative humidity

9.4.3 Packing Specifications

9.4.3.1 Anti-TB Pediatric Category (6-10 kg):

(a) Blister Combipack

PVC Film: Transparent, food grade, blister forming PVC film as

Aluminum Foil: 0.025 mm, VMCH coated Yellow coloured Aluminum

Strip Size: Schedule – 5 : approximately 60 mm x 50 mm ± 10%

The configuration of the different drugs in the blister combi-pack will be as

Laminated material Glassine paper (40 gm)/Aluminum (9um)/Poly (150

Type of Pouch Gusseted

(a) Millboard/ Greyboard

Board: For patient-wise boxes, at least 3 mm corrugated card

Style of box: Top and bottom tuck-in-flap type.

(b) 5-ply shipper Each shipper will contain 20-millboard/greyboard boxes

9.4.3.2 Anti-TB Pediatric Category (11-17 Kg):

(a) Blister Combipack

PVC Film: Transparent, food grade, blister forming PVC film as

Laminated material Glassine paper (40 gm)/Aluminum (9um)/Poly (150

Type of Pouch Gusseted

Board: For patient-wise boxes, at least 3 mm corrugated card